Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Harrow, Inc.(HROW) | 3,990,000 | 3,955,000 | -35,000 | $133.86M | $105.20M | 23.42% | -$28.66M |
| Eton Pharmaceuticals, Inc.(ETON) | 2,852,070 | 2,852,070 | 0 | $37.99M | $37.02M | 8.24% | -$969.7K |
| SANUWAVE Health, Inc.(SNWV) | 0 | 972,002 | +972,002 | $0 | $34.38M | 7.65% | +$34.38M |
| Liquidia Corporation(LQDA) | 1,698,142 | 2,260,000 | +561,858 | $19.97M | $33.34M | 7.42% | +$13.36M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 500,000 | 490,000 | -10,000 | $27.99M | $25.96M | 5.78% | -$2.03M |
| Codexis, Inc.(CDXS) | 8,840,000 | 9,500,000 | +660,000 | $42.17M | $25.55M | 5.69% | -$16.61M |
| Immunome, Inc.(IMNM) | 2,040,000 | 3,550,000 | +1,510,000 | $21.66M | $23.89M | 5.32% | +$2.23M |
| TG Therapeutics, Inc.(TGTX) | 2,260,000 | 535,000 | -1,725,000 | $68.03M | $21.10M | 4.70% | -$46.93M |
| Arvinas, Inc.(ARVN) | 1,625,000 | 1,975,000 | +350,000 | $33.64M | $13.86M | 3.09% | -$19.78M |
| Ocular Therapeutix, Inc.(OCUL) | 4,342,500 | 1,595,000 | -2,747,500 | $37.08M | $11.69M | 2.60% | -$25.39M |
| Edgewise Therapeutics, Inc.(EWTX) | 480,000 | 395,000 | -85,000 | $12.82M | $8.69M | 1.93% | -$4.13M |
| Protara Therapeutics, Inc.(TARA) | 1,825,000 | 1,730,000 | -95,000 | $9.64M | $7.37M | 1.64% | -$2.27M |
| Ginkgo Bioworks Holdings, Inc.CL A(DNA) | 1,200,000 | 1,195,000 | -5,000 | $11.78M | $6.81M | 1.52% | -$4.97M |
| Gossamer Bio, Inc.NOTE 5 000 6 0(GOSS) | 0 | 0 | 0 | $6.09M | $6.32M | 1.41% | +$228.9K |
| Anika Therapeutics Inc | 0 | 395,000 | +395,000 | $0 | $5.94M | 1.32% | +$5.94M |
| Protagonist Therapeutics Inc | 105,000 | 105,000 | 0 | $4.05M | $5.08M | 1.13% | +$1.02M |
| Xoma Corp Del | 250,000 | 253,043 | +3,043 | $6.57M | $5.04M | 1.12% | -$1.53M |
| Trevi Therapeutics, Inc.(TRVI) | 2,317,500 | 795,000 | -1,522,500 | $9.55M | $5.00M | 1.11% | -$4.55M |
| Palvella Therapeutics, Inc.(PVLA) | 0 | 172,357 | +172,357 | $0 | $4.82M | 1.07% | +$4.82M |
| Gossamer Bio, Inc.(GOSS) | 4,490,000 | 4,287,415 | -202,585 | $4.06M | $4.72M | 1.05% | +$654.5K |
| Anaptys Bio Inc | 0 | 250,933 | +250,933 | $0 | $4.66M | 1.04% | +$4.66M |
| Karyopharm Therapeutics IncNOTE 3 000 10 1 | 0 | 0 | 0 | $4.67M | $4.56M | 1.01% | -$112.7K |
| Disc Medicine, Inc.(IRON) | 0 | 85,000 | +85,000 | $0 | $4.22M | 0.94% | +$4.22M |
| Larimar Therapeutics, Inc.(LRMR) | 0 | 1,914,077 | +1,914,077 | $0 | $4.12M | 0.92% | +$4.12M |
| CG Oncology, Inc.(CGON) | 0 | 163,988 | +163,988 | $0 | $4.02M | 0.89% | +$4.02M |
| Acelyrin Inc | 2,235,000 | 1,615,000 | -620,000 | $7.17M | $3.99M | 0.89% | -$3.19M |
| AVITA Medical, Inc.(RCEL) | 0 | 440,000 | +440,000 | $0 | $3.58M | 0.80% | +$3.58M |
| Essa Pharma Inc | 2,209,998 | 2,209,998 | 0 | $3.96M | $3.49M | 0.78% | -$464.1K |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 1,767,500 | 1,985,000 | +217,500 | $5.36M | $3.16M | 0.70% | -$2.20M |
| Cargo Therapeutics Inc | 750,000 | 666,503 | -83,497 | $10.81M | $2.71M | 0.60% | -$8.10M |
| Zymeworks Inc.(ZYME) | 0 | 175,000 | +175,000 | $0 | $2.08M | 0.46% | +$2.08M |
| Biodesix, Inc.(BDSX) | 3,465,000 | 3,225,000 | -240,000 | $5.30M | $2.02M | 0.45% | -$3.29M |
| Stoke Therapeutics, Inc.(STOK) | 25,000 | 300,000 | +275,000 | $275.8K | $2.00M | 0.44% | +$1.72M |
| MBX Biosciences, Inc.(MBX) | 0 | 250,000 | +250,000 | $0 | $1.84M | 0.41% | +$1.84M |
| Optinose Inc | 0 | 193,039 | +193,039 | $0 | $1.77M | 0.39% | +$1.77M |
| Opus Genetics, Inc.(IRD) | 0 | 1,175,000 | +1,175,000 | $0 | $1.55M | 0.34% | +$1.55M |
| iBio, Inc.(IBIO) | 375,000 | 375,000 | 0 | $918.8K | $1.51M | 0.34% | +$588.8K |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 0 | 62,501 | +62,501 | $0 | $1.39M | 0.31% | +$1.39M |
| Nurix Therapeutics, Inc.(NRIX) | 378,500 | 115,000 | -263,500 | $7.13M | $1.37M | 0.30% | -$5.76M |
| Rezolute, Inc.(RZLT) | 465,000 | 465,000 | 0 | $2.28M | $1.35M | 0.30% | -$930.0K |
| Sangamo Therapeutics, Inc.(SGMOQ) | 0 | 1,055,000 | +1,055,000 | $0 | $691.9K | 0.15% | +$691.9K |
| PepGen Inc.(PEPG) | 110,000 | 420,000 | +310,000 | $416.9K | $590.1K | 0.13% | +$173.2K |
| Journey Medical Corporation(DERM) | 0 | 69,323 | +69,323 | $0 | $409.0K | 0.09% | +$409.0K |
| Ventyx Biosciences Inc | 280,000 | 190,000 | -90,000 | $613.2K | $218.5K | 0.05% | -$394.7K |
| Adagio Medical Holdings, Inc.(ADGM) | 110,571 | 110,571 | 0 | $116.1K | $92.1K | 0.02% | -$24.0K |
| AbCellera Biologics Inc.(ABCL) | 965,000 | 0 | -965,000 | $2.83M | $0 | — | -$2.83M |
| Immatics N.V.(IMTX) | 165,000 | 0 | -165,000 | $1.17M | $0 | — | -$1.17M |
| Jasper Therapeutics, Inc.(JSPR) | 400,000 | 0 | -400,000 | $8.55M | $0 | — | -$8.55M |
| Lexeo Therapeutics, Inc.(LXEO) | 130,000 | 0 | -130,000 | $855.4K | $0 | — | -$855.4K |
| Newamsterdam Pharma Company ORDINARY SHARES | 325,000 | 0 | -325,000 | $8.35M | $0 | — | -$8.35M |
| Nuvalent Inc | 58,500 | 0 | -58,500 | $4.58M | $0 | — | -$4.58M |
| REGENXBIO Inc.(RGNX) | 80,000 | 0 | -80,000 | $618.4K | $0 | — | -$618.4K |
| UroGen Pharma Ltd.(URGN) | 220,000 | 0 | -220,000 | $2.34M | $0 | — | -$2.34M |
| Vaxcyte, Inc.(PCVX) | 75,000 | 0 | -75,000 | $6.14M | $0 | — | -$6.14M |